1. Fluoroquinolone use for uncomplicated infections restricted

   News item 28 May 2016 Pages: 1 - 1

2. Health Canada assesses systemic side effects with Eylea

   News item 28 May 2016 Pages: 2 - 2

3. Health Canada opens up consultation on Vanessa's Law

   News item 28 May 2016 Pages: 3 - 3

4. Phase II riociguat study terminated

   Media release 28 May 2016 Pages: 4 - 4

5. PMDA presents investigation results for hepatitis C therapies

   News item 28 May 2016 Pages: 5 - 5

6. PRAC meeting focusses on recombinant factor VIII products

   News item 28 May 2016 Pages: 6 - 6

7. Risk of DRESS syndrome with olanzapine

   News item 28 May 2016 Pages: 7 - 7

8. Serious allergic reactions linked with topical chlorhexidine

   News item 28 May 2016 Pages: 8 - 8

9. SGLT2 inhibitors increase the risk of diabetic ketoacidosis

   News item 28 May 2016 Pages: 9 - 9

10. Pregabalin: increased risk of major birth defects?

    Clinical study 28 May 2016 Pages: 10 - 10

11. Severe UK early childhood poisoning often methadone-related

    Clinical study 28 May 2016 Pages: 11 - 11

12. Vancomycin associated with hypersensitivity reactions

    Clinical study 28 May 2016 Pages: 12 - 12

13. Adalimumab

    Case report 28 May 2016 Pages: 13 - 13

14. Adalimumab/etanercept

    Case report 28 May 2016 Pages: 14 - 14

15. Afatinib/crizotinib/erlotinib

    Case report 28 May 2016 Pages: 15 - 15

16. Alcohol

    Case report 28 May 2016 Pages: 16 - 16

17. Alcohol

    Case report 28 May 2016 Pages: 17 - 17

18. Allopurinol

    Case report 28 May 2016 Pages: 18 - 18

19. Amifampridine/pyridostigmine

    Case report 28 May 2016 Pages: 19 - 19

20. Amikacin

    Case report 28 May 2016 Pages: 20 - 20

21. Aminolevulinic-acid

    Case report 28 May 2016 Pages: 21 - 21

22. Amoxicillin/clarithromycin/vonoprazan

    Case report 28 May 2016 Pages: 22 - 22

23. Amoxicillin/paracetamol

    Case report 28 May 2016 Pages: 23 - 23

24. Anakinra

    Case report 28 May 2016 Pages: 24 - 24

25. Antineoplastic/doxorubicin

    Case report 28 May 2016 Pages: 25 - 25

26. Antineoplastics

    Case report 28 May 2016 Pages: 26 - 26

27. Antineoplastics

    Case report 28 May 2016 Pages: 27 - 27

28. Antipsychotics

    Case report 28 May 2016 Pages: 28 - 28

29. Antipsychotics/metoclopramide

    Case report 28 May 2016 Pages: 29 - 29

30. Antithymocyte globulin

    Case report 28 May 2016 Pages: 30 - 30

31. Antivenin-elapidae

    Case report 28 May 2016 Pages: 31 - 31

32. Antivirals

    Case report 28 May 2016 Pages: 32 - 32

33. Apremilast

    Case report 28 May 2016 Pages: 33 - 33

34. Aripiprazole

    Case report 28 May 2016 Pages: 34 - 34

35. Atazanavir/ivabradine/ritonavir interaction

    Case report 28 May 2016 Pages: 35 - 35

36. Axitinib

    Case report 28 May 2016 Pages: 36 - 36

37. Azathioprine

    Case report 28 May 2016 Pages: 37 - 37

38. Azathioprine

    Case report 28 May 2016 Pages: 38 - 38

39. Azathioprine

    Case report 28 May 2016 Pages: 39 - 39

40. Azathioprine/infliximab/prednisone

    Case report 28 May 2016 Pages: 40 - 40

41. BCG vaccine

    Case report 28 May 2016 Pages: 41 - 41

42. Bendamustine/brentuximab vedotin

    Case report 28 May 2016 Pages: 42 - 42

43. Bendamustine/rituximab

    Case report 28 May 2016 Pages: 43 - 43

44. Benzocaine

    Case report 28 May 2016 Pages: 44 - 44

45. Benzodiazepine abuse/withdrawal

    Case report 28 May 2016 Pages: 45 - 45

46. Bevacizumab

    Case report 28 May 2016 Pages: 46 - 46

47. Bevacizumab

    Case report 28 May 2016 Pages: 47 - 47

48. Bevacizumab

    Case report 28 May 2016 Pages: 48 - 48

49. Bevacizumab/pazopanib

    Case report 28 May 2016 Pages: 49 - 49

50. Bleomycin

    Case report 28 May 2016 Pages: 50 - 50